MacroGenics sells GMP manufacturing operations to Bora Pharma for $122.5M upfront

MACROGENICS INC

Bora pays $122.5M cash at closing for MacroGenics' CDMO business, including Rockville site (11,000 L capacity) and Frederick warehouse.
Up to $5M in additional milestone payments to MacroGenics based on 2027-2028 CDMO manufacturing and professional development services.
Approximately 140 MacroGenics employees expected to be hired by Bora; transaction expected to close in Q3 2026.
MacroGenics will enter supply and transition services agreements to retain clinical manufacturing support for its pipeline.
Transaction approved by both boards; subject to customary closing conditions and consents.

item 1.01item 7.01item 9.01

Source: SEC EDGAR

accession 0001125345-26-000035

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.